Works by Zou, Guo-rong

Results: 7
    1
    2

    Systemic longitudinal immune profiling identifies proliferating Treg cells as predictors of immunotherapy benefit: biomarker analysis from the phase 3 CONTINUUM and DIPPER trials.

    Published in:
    Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-01988-w
    By:
    • Huang, Sai-Wei;
    • Jiang, Wei;
    • Xu, Sha;
    • Zhang, Yuan;
    • Du, Juan;
    • Wang, Ya-Qin;
    • Yang, Kun-Yu;
    • Zhang, Ning;
    • Liu, Fang;
    • Zou, Guo-Rong;
    • Jin, Feng;
    • Wu, Hai-Jun;
    • Zhou, Yang-Ying;
    • Zhu, Xiao-Dong;
    • Chen, Nian-Yong;
    • Xu, Cheng;
    • Qiao, Han;
    • Liu, Na;
    • Sun, Ying;
    • Ma, Jun
    Publication type:
    Article
    3
    4
    5
    6

    Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical Trial.

    Published in:
    JAMA: Journal of the American Medical Association, 2025, v. 333, n. 18, p. 1589, doi. 10.1001/jama.2025.1132
    By:
    • Liang, Ye-Lin;
    • Liu, Xu;
    • Shen, Liang-Fang;
    • Hu, Guang-Yuan;
    • Zou, Guo-Rong;
    • Zhang, Ning;
    • Chen, Chuan-Ben;
    • Chen, Xiao-Zhong;
    • Zhu, Xiao-Dong;
    • Yuan, Ya-Wei;
    • Yang, Kun-Yu;
    • Jin, Feng;
    • Hu, Wei-Han;
    • Xie, Fang-Yun;
    • Huang, Ying;
    • Han, Fei;
    • Tang, Ling-Long;
    • Mao, Yan-Ping;
    • Lu, Li-Xia;
    • Sun, Rui
    Publication type:
    Article
    7